NDC Package 49281-924-50 Fluzone Quadrivalent Northern Hemisphere

View Billable Units, 11-Digit Format, RxNorm

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
49281-924-50
Package Description:
10 SYRINGE, GLASS in 1 PACKAGE / .5 mL in 1 SYRINGE, GLASS (49281-924-88)
Product Code:
Proprietary Name:
Fluzone Quadrivalent Northern Hemisphere
Usage Information:
Fluzone® Quadrivalent is a vaccine indicated for active immunization for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.Fluzone Quadrivalent is approved for use in persons 6 months of age and older.
11-Digit NDC Billing Format:
49281092450
NDC to RxNorm Crosswalk:
  • RxCUI: 2709119 - influenza virus vaccine 2025 (quadrivalent - Croatia/Victoria/Michigan/Phuket) 0.5 ML Prefilled Syringe
  • RxCUI: 2709119 - 0.5 ML influenza A virus A/Croatia/10136RV/2023 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe
  • RxCUI: 2709125 - influenza virus vaccine 2025 (quadrivalent - Croatia/Victoria/Michigan/Phuket) Injectable Suspension
  • RxCUI: 2709125 - influenza A virus A/Croatia/10136RV/2023 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension
  • RxCUI: 2719474 - Fluzone Quadrivalent 2025-2026 vaccine Injectable Suspension
Labeler Name:
Sanofi Pasteur Inc.
Sample Package:
No
FDA Application Number:
BLA103914
Marketing Category:
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date:
07-01-2024
End Marketing Date:
07-16-2025
Listing Expiration Date:
07-16-2025
Exclude Flag:
D
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 49281-924-50?

The NDC Packaged Code 49281-924-50 is assigned to a package of 10 syringe, glass in 1 package / .5 ml in 1 syringe, glass (49281-924-88) of Fluzone Quadrivalent Northern Hemisphere, labeled by Sanofi Pasteur Inc.. The product's dosage form is and is administered via form.

Is NDC 49281-924 included in the NDC Directory?

No, Fluzone Quadrivalent Northern Hemisphere with product code 49281-924 is excluded from the NDC Directory because it was discontinued by the manufacturer. The product was first marketed by Sanofi Pasteur Inc. on July 01, 2024 and its listing in the NDC Directory is set to expire on July 16, 2025 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 49281-924-50?

The 11-digit format is 49281092450. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-249281-924-505-4-249281-0924-50